Evidence Hub

Tadalafil Attenuates Angiotensin II-Induced Extracellular Matrix Remodeling in Cardiac Fibroblasts Through TGF-β1/Smad3 Signaling Pathway

Wenyi Ye, Junling Huang, J. Yang, Ling Wang, Jin Dai, Xiao Wang

Journal of Biomedical Nanotechnology, 2023

Abstract

Cardiac fibrosis is a common consequence of various cardiac diseases and is linked to the activation of cardiac fibroblasts (FBs). This study aimed to investigate the effect of tadalafil (Tad) on cardiac fibrosis by regulating FB transformation and its molecular mechanism. Angiotensin

II (Ang II) treated FBs were used to construct in vitro cardiac fibrosis models. FBs were divided into three groups: control, Ang II, and Ang II+Tad. Immunofluorescence, real-time quantitative PCR, Western blot, and flow cytometry were utilized to detect the expression of α-SMA,

collagen types I and III, fibronectin, Bcl-2, Bax, Bad, TGF-β1, SMAD3, p-SMAD3, and apoptosis. The expression of α-SMA, collagen types I and III, fibronectin, and Bcl-2 in the Ang II+Tad group was significantly decreased, while the expressions of Bax and Bad were increased

compared to the Ang II group. The Ang II+Tad group also had the highest proportion of apoptosis. The TGF-β1/Smad3 signaling pathway was found to be inhibited in the Ang II+Tad group. Therefore, Tad can inhibit Ang II-induced FB activation through the TGF-β1/Smad3 pathway

and promote apoptosis of activated FBs.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free